Literature DB >> 7153288

Determination of medroxyprogesterone acetate in plasma by high-performance liquid chromatography.

G Milano, G Carle, N Renée, J L Boublil, M Namer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7153288     DOI: 10.1016/s0378-4347(00)84182-1

Source DB:  PubMed          Journal:  J Chromatogr


× No keyword cloud information.
  6 in total

1.  Benefits of Medroxyprogesterone Acetate (MPA) in Advanced or Recurrent Breast Cancer with Higher Serum Concertration.

Authors: 
Journal:  Breast Cancer       Date:  1995-10-31       Impact factor: 4.239

Review 2.  Clinical pharmacokinetics of endocrine agents used in advanced breast cancer.

Authors:  P E Lønning; E A Lien; S Lundgren; S Kvinnsland
Journal:  Clin Pharmacokinet       Date:  1992-05       Impact factor: 6.447

3.  Plasma concentrations of medroxyprogesterone acetate and megesterol acetate during long-term follow-up in patients treated for metastatic breast cancer.

Authors:  A A Miller; R Becher; C G Schmidt
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

4.  Pharmacoclinical data on high dose medroxyprogesterone acetate in advanced breast cancer.

Authors:  M Namer; G Milano; R Khater; M Frenay; A Thyss; N Renée
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

5.  Influence of aminoglutethimide on the metabolism of medroxyprogesterone acetate and megestrol acetate in postmenopausal patients with advanced breast cancer.

Authors:  S Lundgren; P E Lønning; A Aakvaag; S Kvinnsland
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

Review 6.  Pharmacokinetics, metabolism and serum concentrations of progestins used in contraception.

Authors:  Alexis J Bick; Renate Louw-du Toit; Salndave B Skosana; Donita Africander; Janet P Hapgood
Journal:  Pharmacol Ther       Date:  2020-12-13       Impact factor: 13.400

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.